©The Author(s) 2015.
World J Gastroenterol. Nov 21, 2015; 21(43): 12468-12481
Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12468
Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12468
Table 2 Baseline characteristics n (%)
| Patients with MGOO | 1281 (100) |
| Cause of MGOO | |
| Gastric cancer | 536 (41.8) |
| Pancreatic cancer | 479 (37.4) |
| Bile duct cancer | 79 (6.2) |
| Duodenal cancer | 42 (3.3) |
| Gallbladder cancer | 37 (2.9) |
| Ampullary cancer | 14 (1.1) |
| Other malignancies | 86 (6.7) |
| Unknown | 8 (0.6) |
| Biliary obstruction1 | |
| Yes | 432 (52.9) |
| No | 384 (47.1) |
| Stent type | |
| Uncovered SEMS | 970 (75.7) |
| Partially covered SEMS | 311 (24.3) |
| No. of enteral stents inserted at initial procedure2 | |
| Single stent | 692 (93.5) |
| Two stents | 48 (6.5) |
- Citation: van Halsema EE, Rauws EA, Fockens P, van Hooft JE. Self-expandable metal stents for malignant gastric outlet obstruction: A pooled analysis of prospective literature. World J Gastroenterol 2015; 21(43): 12468-12481
- URL: https://www.wjgnet.com/1007-9327/full/v21/i43/12468.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i43.12468